Address book
Contacts
MARCO SCARPA
Position
Ricercatore a tempo det. art. 24 c. 3 lett. B L. 240/2010
Address
VIA GIUSTINIANI, 2 - PADOVA
Telephone
Marco Scarpa obtained the Certificate of Proficiency in English of the University of Cambridge in 1992: He graduated at the Medical School of the University of Padova in 1997 and he obtained the General Surgery specialization in 2003. He attended to Queen Elizabeth Hospital (Birmingham), Mount Sinai Hospital (Toronto), and Academisch Medisch Centrum (Amsterdam) as honorary research fellow. In 2007, he discussed his PhD thesis in “Surgical Sciences and Technical Applications”. Since 2010 till 2018 he has been staff surgeon at the department of Oncological Surgery Department of the Veneto Institute of Oncology, Padova and since 2018 he is staff surgeon at the General Surgery Unit of the University Hospital of Padova. His interests are in quality of life after surgery for IBD, colorectal and esophageal cancer and in immunosurveillance for colorectal and esophageal cancer. He is principal investigator in several studies and he is author of more than 230 articles appeared on Pubmed with an h-index of 34. He is cohordinating several research projects. He serves as Associated Editor in various journals, including Cancer medicine, Digestive Surgery and Frontiers in Surgical Oncology.
Positions and Employment
•Feb 2024 – present:Researcher at University of Padova, Department of Surgical, Oncological and gastroenterological Sciences, Padova, Italy. Main research lines focused on colorectal and esophageal carcinogenesis and immune surveillance mechanisms and on quality of life after surgery. Practicing emergency and colorectal surgery.
•Jan 2018 – Jan 2024:Staff surgeon at University Hospital of Padova, General Surgery Unit and General Surgery 3 Unit, Padova, Italy. Main research lines focused on colorectal and esophageal carcinogenesis and immune surveillance mechanisms and on quality of life after surgery. Practicing emergency and colorectal surgery.
•Feb 2010 – Jan 2018: Staff surgeon at Istituto Oncologico Veneto, Esophageal and Digestive Tract Surgical Unit, Padova, Italy. Cohordinating the research activity of the esophageal and colorectal surgery unit. Main research lines focused on colorectal and esophageal carcinogenesis and immune surveillance mechanisms and on quality of life after surgery. Practicing oncological, esophageal and colorectal surgery.
•Jun 2009 – Jan 2010: Staff surgeon at Azienda ULSS numero 10 Veneto Orientale, General Surgery Unit, Presidio Ospedaliero di Jesolo, Jesolo, Italy. General surgery practice, emergency surgery, colorectal surgery, cholecystectomy, colorectal cancer endoscopic screening program
•Jun 2007 – Jun 2009: Staff surgeon at Ospedale Classificato “Villa Salus”, General Surgery Unit, Mestre Venezia, Italy. General surgery practice, emergency surgery, colorectal surgery, cholecystectomy, hernia surgery and proctology
Notices
Orari di ricevimento
Lunedì from 15:00 to 16:00
Settimo piano del policlinico (studio)Previo appuntamento (marco. scarpa@unipd. it)
Pubblicazioni
•in My Bibliography:
https://www.ncbi.nlm.nih.gov/myncbi/marco.scarpa.1/bibliography/public/
•in Scopus:
https://www.scopus.com/results/results.uri?sort=plf-f&src=s&st1=Scarpa&st2=Marco&nlo=1&nlr=20&nls=count-f&sid=31c465590c9a9e4ed0cce9ba759507e3&sot=anl&sdt=aut&sl=34&s=AU-ID%28%22Scarpa%2c+Marco%22+57225685858%29&txGid=f27bd493eee28b4012ca34981a5da8c6
Area di ricerca
•Quality of life after surgery of the digestive tract for malignant and benign pathology: use of generic questionnaires and specific disease and their validation. He ideated and coordinated two randomized controlled trials QOLEC1 step 1 (ClinicalTrials.gov identifier NCT01738620) and QOLEC1 step 2 (ClinicalTrials.gov identifier NCT01738633) spontaneous monocentric that have the aim of evaluating the effectiveness of psychological support, nutritional support and pneumological support in patients undergoing esophagectomy for cancer. It also ideated and still coordinates the randomized controlled trial BIPORT (ClinicalTrials.gov identifier NCT02075580) spontaneous monocentric RCT which aims to evaluate the effectiveness of psychological support in patients undergoing port a cath positioning for chemotherapy. He took part in the european multicenter study on post esophagectomy symptoms (LASER studies)
•Immunosurveillance mechanisms in colorectal carcinoma and adenocarcinoma of the esophagus: analysis of immuno-surveillance mechanisms and lymph node spread and their clinical implications. He ideated and still coordinates the prospective MICCE1 study which aims to assess the effectiveness of immunosurveillance markers at the level of the colic and esophageal mucosa in predicting the possible regression of preneoplastic lesions in patients with ulcerative colitis and Barrett's esophagus. These principles were then applied in the study of patients undergoing electrochemotherapy for melanoma and metastatic breast cancer (IMECT study) and in patients with rectal cancer. In fact, he designed and still coordinates the IMMUNOREACT project involving several surgical centers (Padua, Treviso, Belluno, Montepulciano, Reggio Emilia and many more) and which aims to analyze the molecular predictors of lymph node metastases in early rectal carcinoma and complete response in carcinoma locally advanced rectum.
•Clinical management of patients with cancer of the digestive tract: cancer of the esophagus, neuroendocrine cancer of the digestive tract, GIST and colorectal cancer. Analysis of disease markers and prognostic factors. Particular attention was paid to the impact of cancer surgery on the elderly and obese patients. Participate in the multicenter study coordinated by the University of Birmingham on gastric esophagus anastomis (OGAA)
•Pathogenesis of ulcerative colitis and pouchitis: role of costimulation molecules, the microbiota and innate immunity at the level of the colic and ileal mucosa. It also coordinates the randomized controlled trial spontaneous monocentric MEP1 which aims to evaluate the efficacy of supplementation with probiotics in patients undergoing restorative proctocolectomy for the prevention of pouchitis.
•Long-term outcome after surgery for Crohn's disease: recurrence and its clinical and molecular predictive factors. Particular attention is paid to the analysis of the immune microenvironment of the ileal mucosa and to the cytokine network.
•Ileostomies and colostomy: indications, long-term outcome, quality of life and surgical solutions. Currently, he has ideated and is organizing the project STOPADO on complications of digestive stoma and on quality of life of digestive stoma.
